FDA Biosimilars Program Gets Seed Money In Administration's FY '11 Budget
This article was originally published in The Pink Sheet Daily
Executive Summary
Agency again requests generic user fee program, seeking to add $38 million in industry funds to $88.5 million in federal money for reviewing generics.
You may also be interested in...
FDA Appropriations In Senate: Money For Generics; Worry About Tobacco
Senate appropriators would like to see FDA spend $93 million in fiscal year 2010 on its generic drugs program
Cancer-Genomics Firm Quanticel Debuts With Close Ties To Celgene, And An Exit In Mind
Celgene will get exclusive use of Quanticel's single-cell genomic analysis to tweak its clinical pipeline, and it also has exclusive options to acquire the venture-backed start-up.
One Trial Plus Supportive Evidence Is Enough For Hospital-, Ventilator-Acquired Pneumonia Indication, Panel Says
Anti-Infective Drugs Advisory Committee members viewed one-trial as practical means of gaining efficacy data.